Machinery & Materials
Logistics & Cold Chain
More from Sanofi
Sanofi Clinical Trial Benefits from Compact, Multi-Lingual Booklet Label
Specialty Label for Needle Protection System in International Phase III Trial.
May 15th, 2020
Cancer-Linked Contaminant Found in Heartburn Pills
Low levels of NDMA have been found in samples of the heartburn medication Zantac, according to the FDA.
Sep 18th, 2019
Brexit Contingency Plans for Pharma Industry
The EU currently supplies two-thirds of the medicines in the UK. How will Brexit affect pharmaceutical investments and manufacturing?
Feb 28th, 2019
Sanofi Recharges Nasacort With Package Redesign
Modernized structural and graphical design includes bolder colors, a window that lets consumers see product, and eliminates the need for an outer carton.
Jan 27th, 2019
FDA Approves 6-in-1 Vaccine for Kids
The FDA just approved a new combination vaccine from Sanofi and Merck that contains six different antigens.
Jan 3rd, 2019
FDA Approves $37,000/Yr Eczema Drug
Regeneron and Sanofi’s Dupixent is a breakthrough in treating severe eczema, but it doesn’t come cheap.
Apr 3rd, 2017
Sanofi Takes on Rituximab in Asian Biosimilar Market
Sanofi inks deal with Taiwan’s JHL Biotech to create biosimilar that could take over China’s cancer market.
Dec 8th, 2016
Return of EpiPen Rival
EpiPen alternative, Auvi-Q, announced a 2017 return to market, but will it drive prices down?
Oct 27th, 2016
Sanofi Study Reveals Perceptions of Counterfeit Medicines
Most Americans associate counterfeiting with consumer goods rather than meds. Sanofi introduces three levels of package protection to battle counterfeits.
Nov 23rd, 2015